Overview of the Global Overactive Bladder Treatment Market:

The Global Overactive Bladder Treatment Market is expected to register a CAGR of about 2.9% over the forecast period, 2018-2023.

The overactive bladder treatments includes various therapies like, anticholinergics, mirabegron, etc., that are used to treat the sudden, involuntary contraction of the muscle in the urinary bladder wall leading to urinary urgency, frequency, nocturia, and urge-incontinence.

Get a Sample Copy of this Report @ https://marketprognosis.com/sample-request/17149 .

In 2017, there were approximately 950 million people who were 60 years old or above, comprising 13% of the global population, and is growing by about 3% every year. Incontinence generally increases with aging. As per a global population-based survey, the estimated prevalence of overactive bladder (OAB) in Europe and Canada was found to be 12.8% in women and 10.8% in men. OAB has a major negative impact on quality of life and health of the aged population. With the increasing burden of OAB, along with other urinary diseases, the growth of the overactive bladder treatment market is likely to be high. Other factors, such as the development of innovative intravesical therapies and aggressive marketing by pharmaceuticals companies, are also expected to expand the market.

Anticholinergic have been linked to the burden to dementia or Alzheimer’s disease in a few recent studies. In a recent publication by SL Gray, 3434 participants were studied and a 10-year cumulative dose response relationship was found to exist between the usage of anticholinergic drugs and the risk of developing dementia. Anticholinergic has also been linked with increased mortality and cardiovascular diseases. These factors may deter healthcare providers from using these treatment options. Also the increasing awareness about these side effects among users will lead to the slowdown of the growth of this market.

Purchase this report online with 107 Pages, Top Key Players Analysis and List of Tables & Figure @ https://marketprognosis.com/buyReport/17149 .

North America has dominated the overactive bladder treatment market, which can be primarily attributed to its well-established healthcare industry which has favorable reimbursement of overactive bladder treatment, growing prevalence of the disease with rising age, and the presence of major players. Asia-Pacific region is expected to witness the highest CAGR during the forecast period, due to rising prevalence of bladder overactivity, increasing geriatric population, rising healthcare expenditure, and growing awareness of overactive bladder.

Major Key Players:

1 Allergan PLC

2 Apotex Inc.

3 Astellas Pharma Inc.

4 Aurobindo Pharma Limited

5 Cogentix Medical Inc

6 Endo International PLC

7 Hisamitsu Pharmaceutical Co. Inc

8 Intas Pharmaceuticals Ltd

9 Johnson & Johnson

10 Macleods Pharmaceuticals Ltd and More…………

Any Query? Ask to our Expert @ https://marketprognosis.com/enquiry/17149 .

This study answers to the below key questions:

1 What will the market size be in 2023 and what will the growth rate be?

2 What are the key market trends?

3 What is driving this market?

4 What are the challenges to market growth?

5 Who are the key vendors in this market space?

6 What are the market opportunities and threats faced by the key vendors?

7 What are the strengths and weaknesses of the key vendors?

In the end, this report covers data and information on capacity and production overview, production, market share analysis, sales overview, supply, sales, and shortage, import, export and consumption as well as cost, price, revenue and gross margin of Overactive Bladder Treatment Market.

Table of Contents:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Key Inferences

5 Market Overview

6 Drivers, Restraints, Opportunities and Challenges Analysis (Droc)

7 Market Segmentation

8 Competitive Landscape

9 Key Players

10 Future Outlook of the Market

Contact us:

ProgMark Pvt. Ltd.

Thane – 421501

India.

[email protected]

+1 973 241 5193

https://www.marketprognosis.com